MedUni Vienna Archives - The Hippocratic Post

Enhanced Therapy for Gestational Diabetes through New Subgroups

Posted on June 23, 2024 by Hippocratic Post

Patients with gestational diabetes show different disease progressions and therefore require personalised treatment measures. An international research team led by MedUni Vienna has now identified three subgroups of the disease with different treatment needs. The results of the study, recently published in the prestigious journal “Diabetologia”, could improve our understanding of gestational diabetes and significantly […]

New drug expands treatment opportunities for rheumatoid arthritis

Posted on August 25, 2022 by Hippocratic Post

In its final Phase III clinical trial, a new drug for treating rheumatoid arthritis has proved to be at least as effective as the current “gold standard” treatment for this autoimmune disease. This opens up new treatment options for affected patients. The results of the international multicentre study led by MedUni Vienna were recently published […]

New biomarker can predict MS severity

Posted on August 10, 2022 by Hippocratic Post

It is essential to assess the severity of multiple sclerosis (MS) in order to choose appropriate therapeutic measures, but this cannot be reliably done using existing methods. A MedUni Vienna study now shows for the first time that the retina can be used as a prognostic marker. Analyses revealed that retinal layer thinning as a […]

New guidelines for the diagnosis and treatment of brain metastases

Posted on August 11, 2021 by Hippocratic Post

Brain metastases are a common and dangerous complication in cancer patients. Under the leadership of experts from MedUni Vienna, two of the largest international oncology societies have published new clinical guidelines for the diagnosis and treatment of brain metastases from solid tumours. The recommendations have recently been published in the leading journal “Annals of Oncology” […]

Vaccine supports immune response in immunosuppressed

Posted on August 4, 2021 by Hippocratic Post

Research from MedUni Vienna demonstrates that SARS-CoV-2 vaccination supports immune response in immunosuppressed patients Patients under immunosuppressive therapy can still develop good immune responses to a SARS-CoV-2 vaccination. A third dose of vaccine might be necessary for those patients who are unable to produce antibodies. This is indicated by a recent MedUni Vienna study. Patients […]

Lung cancer immunotherapy treatment

Posted on July 9, 2021 by Hippocratic Post

Potential marker for success of immunotherapy in the treatment of lung cancer: Lung cancer has the highest mortality rate of all cancers, and treatment options are extremely limited, especially for patients with oncogenic mutations in the KRAS gene. A great deal of hope was invested in the licensing of immune checkpoint inhibitors, but the reality […]

Chronic inflammatory liver disease

Posted on March 31, 2021 by Hippocratic Post

Chronic inflammatory liver disease: cell stress mechanisms identified as prognostic factor: PSC is a rare disease with a poor prognosis and can lead to cirrhosis of the liver or bile duct cancer. It affects 0.01% of the population but, even though it is rare, PSC is responsible for more than 10% of all liver transplants, […]

How inflammatory signalling molecules contribute to carcinogenesis

Posted on February 22, 2021 by Hippocratic Post

How inflammatory signalling molecules contribute to carcinogenesis: A team of MedUni Vienna researchers led by Johannes A. Schmid at the Center for Physiology and Pharmacology, Institute of Vascular Biology and Thrombosis Research, has managed to identify a previously unknown molecular connection between an inflammatory signalling molecule and one of the main oncogenes. The study has […]

Latest international brain tumour research

Posted on July 15, 2020 by Hippocratic Post

New findings about brain tumour development could lead to more effective treatment. For the first time in the world, an international study team with substantial participation from researchers from the Comprehensive Cancer Center (CCC) of MedUni Vienna and Vienna University Hospital identifies the molecular differences between individual tumour cells in ependymomas, which are an aggressive […]